Position in MRNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,320,138,818
+$1,493,082,599 QoQ
Shares Held
45,672,024
+62.9% QoQ
Ownership
11.5%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.78021994383258.ToString("F0")%
Shared 0.ToString("F0")%
None 0.21978005616742538.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,683,576,696 across 351 Biotechnology names. MRNA ranks #3 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
This page
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in MRNA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,320,138,818 | 45,672,024 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $827,056,219 | 28,045,311 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $317,819,990 | 12,304,297 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $542,018,350 | 19,645,464 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $599,036,320 | 21,130,029 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $776,075,478 | 18,664,634 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,161,650,085 | 17,382,165 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,512,902,591 | 21,161,285 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,449,198,627 | 13,599,837 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $635,818,754 | 6,393,351 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $397,002,548 | 3,843,572 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $542,362,270 | 4,463,887 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $608,820,912 | 3,964,194 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $663,704,879 | 3,695,050 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $253,763,198 | 2,145,989 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $386,645,521 | 2,706,654 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $387,009,994 | 2,246,662 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,066,648,185 | 4,199,733 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,832,851,700 | 7,360,733 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $1,695,385,163 | 7,215,019 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $754,609,718 | 5,762,579 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $830,087,173 | 7,945,699 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $2,421,158,672 | 34,221,324 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,409,938,901 | 37,532,143 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $741,543,759 | 24,759,391 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||